More patent troubles about genes.

Nature · 1994

editorial · Level V

Where this comes from

Abstract

Two decisions by the British Appeal Court raise questions about the allowable breadth of biotechnology patents, but point to the charges patent-holders should be free to make.

Medical subject headings